Literature DB >> 2179616

Growth hormone and growth hormone binding protein in human urine.

N Hattori1, A Shimatsu, Y Kato, H Imura.   

Abstract

The presence of growth hormone binding protein (GH-BP) in urine was demonstrated in normal subjects. Scatchard analysis showed that an association constant (Ka) and a maximum binding capacity (Bmax) of urinary GH-BP were 2.3 +/- 0.8 x 10(8) M-1 and 19.2 +/- 4.0 ng/mg urinary protein, respectively. The molecular weight of the urinary GH-BP was estimated to be 50000 to 70000 on gel chromatography. Although the molecular weight and Ka were similar to those of plasma GH-BP, Bmax of urinary GH-BP was significantly higher than that of plasma GH-BP (0.44 +/- 0.12 ng/mg protein). GH-BP in urine may be derived from plasma and/or renal tubules.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2179616     DOI: 10.1038/ki.1990.70

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  4 in total

Review 1.  Nanoparticle technology: amplifying the effective sensitivity of biomarker detection to create a urine test for hGH.

Authors:  Claudia Fredolini; Davide Tamburro; Guido Gambara; Benjamin S Lepene; Virginia Espina; Emanuel F Petricoin; Lance A Liotta; Alessandra Luchini
Journal:  Drug Test Anal       Date:  2009-09       Impact factor: 3.345

2.  Plasma growth hormone-binding activity is low in uraemic children.

Authors:  M C Postel-Vinay; A Tar; H Crosnier; M Broyer; R Rappaport; B Tönshoff; O Mehls
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

3.  Metabolic clearance of recombinant human growth hormone in health and chronic renal failure.

Authors:  D Haffner; F Schaefer; J Girard; E Ritz; O Mehls
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

4.  Growth hormone and insulin-like growth factor-1 in blood and urine as response markers during treatment of acromegaly with octreotide: a double-blind placebo-controlled study.

Authors:  L Fredstorp; S Werner
Journal:  J Endocrinol Invest       Date:  1993-04       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.